Cite
HARVARD Citation
Hillus, D. et al. (2021). Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study. Lancet. 9 (11), pp. 1255-1265. [Online].